Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Krystal Biotech (KRYS) Profit After Tax (2021 - 2025)

Historic Profit After Tax for Krystal Biotech (KRYS) over the last 5 years, with Q4 2025 value amounting to $51.4 million.

  • Krystal Biotech's Profit After Tax rose 1301.92% to $51.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $204.8 million, marking a year-over-year increase of 12973.68%. This contributed to the annual value of $204.8 million for FY2025, which is 12973.68% up from last year.
  • As of Q4 2025, Krystal Biotech's Profit After Tax stood at $51.4 million, which was up 1301.92% from $79.4 million recorded in Q3 2025.
  • In the past 5 years, Krystal Biotech's Profit After Tax registered a high of $80.7 million during Q3 2023, and its lowest value of -$50.0 million during Q1 2022.
  • Its 5-year average for Profit After Tax is $4.8 million, with a median of -$7.3 million in 2021.
  • Its Profit After Tax has fluctuated over the past 5 years, first crashed by 21599.42% in 2022, then skyrocketed by 373401.29% in 2025.
  • Over the past 5 years, Krystal Biotech's Profit After Tax (Quarter) stood at -$21.8 million in 2021, then crashed by 46.99% to -$32.1 million in 2022, then skyrocketed by 127.12% to $8.7 million in 2023, then soared by 423.23% to $45.5 million in 2024, then grew by 13.02% to $51.4 million in 2025.
  • Its Profit After Tax stands at $51.4 million for Q4 2025, versus $79.4 million for Q3 2025 and $38.3 million for Q2 2025.